Use of Zoledronic Acid in the Treatment of Paget's Disease

DSpace/Manakin Repository

Use of Zoledronic Acid in the Treatment of Paget's Disease

Citable link to this page

. . . . . .

Title: Use of Zoledronic Acid in the Treatment of Paget's Disease
Author: Seton, Margaret P.; Krane, Stephen Martin

Note: Order does not necessarily reflect citation order of authors.

Citation: Seton, Margaret, and Stephen M. Krane. 2007. Use of zoledronic acid in the treatment of Paget's disease. Therapeutics and Clinical Risk Management 3(5): 913-918.
Full Text & Related Files:
Abstract: This review examines the use of zoledronic acid in the treatment of Paget’s disease of bone. It begins with a brief discussion of the theories of pathogenesis of Paget’s disease, its clinical manifestations, and the history of bisphosphonate treatment in this disorder. Risk of oversuppression of bone by the more potent bisphosphonates and their association with avascular necrosis of the jaw are noted.
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376069/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:5310895

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters